Ladenburg Thalmann Downgrades Aviragen (AVIR) to Neutral
Tweet Send to a Friend
Ladenburg Thalmann downgraded Aviragen (NASDAQ: AVIR) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
